A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 169 (6), 567-571
- https://doi.org/10.1016/s0002-9610(99)80222-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prophylaxis of postoperative thromboembolism with low molecular weight heparinsBritish Journal of Surgery, 1993
- Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgeryThe Lancet, 1993
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992
- Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisThe Lancet, 1992
- Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgeryBritish Journal of Surgery, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General SurgeryThrombosis and Haemostasis, 1988
- Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosisBritish Journal of Surgery, 1988
- Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosisBritish Journal of Surgery, 1986
- 125I-LABELLED FIBRINOGEN TEST ADAPTED FOR ROUTINE SCREENING FOR DEEP-VEIN THROMBOSISThe Lancet, 1970